Predictors of Mortality in Elderly Subjects with Obstructive Airway Disease: The PILE Score

Annals of Epidemiology

Volumn 20, Issue 3, 2010, Pages 223-232

  Mehrotra, Nitin ^a   Freire, Amado X ^a   Bauer, Douglas C ^b   Harris, Tamara B ^c   Newman, Anne B ^d   Kritchevsky, Stephen B ^e   Meibohm, Bernd ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST UNIVERSITY   (United States)

Author keywords

Cox Proportional Hazards Modeling; Elderly; Interleukin 6; Mortality; Obstructive Airway Disease

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL DECISION MAKING; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HIGH RISK PATIENT; HUMAN; INFLAMMATION; KNEE FUNCTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OBSTRUCTIVE AIRWAY DISEASE; PHYSICAL CAPACITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SPIROMETRY; WALKING;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PENNSYLVANIA; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TENNESSEE;

EID: 75949117459     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.11.005     Document Type: Article

References (51)

1. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
2. Lange P., Nyboe J., Appleyard M., Jensen G., and Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 45 (1990) 579-585
3. Tockman M.S., and Comstock G.W. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. Am Rev Respir Dis 140 (1989) S56-S63
4. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
5. Janssen K.J., Moons K.G., Kalkman C.J., Grobbee D.E., and Vergouwe Y. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol 61 (2008) 76-86
6. Briggs A., Spencer M., Wang H., Mannino D., and Sin D.D. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Arch Intern Med 168 (2008) 71-79
7. Jones R.C., Donaldson G.C., Chavannes N.H., et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease-The DOSE Index. Am J Respir Crit Care Med (2009)
8. Puhan M.A., Garcia-Aymerich J., Frey M., et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 374 (2009) 704-711
9. National Institutes of Aging. Health ABC Description. Available at: http://www.nia.nih.gov/ResearchInformation/ScientificResources/HealthABCDescription.htm. Accessed May 15, 2009.
10. Newman A.B., Simonsick E.M., Naydeck B.L., et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 295 (2006) 2018-2026
11. Yende S., Waterer G.W., Tolley E.A., et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 61 (2006) 10-16
12. Hankinson J.L., Odencrantz J.R., and Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159 (1999) 179-187
13. Landbo C., Prescott E., Lange P., Vestbo J., and Almdal T.P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1856-1861
14. Waterer G.W., Wan J.Y., Kritchevsky S.B., et al. Airflow limitation is underrecognized in well-functioning older people. J Am Geriatr Soc 49 (2001) 1032-1038
15. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 152 (1995) 1107-1136
16. American Thoracic Society. Standards for the Diagnosis and Management of COPD. Available at: http://www.thoracic.org/sections/copd/resources/copddoc.pdf. Accessed May 15, 2009.
17. Simonsick E.M., Montgomery P.S., Newman A.B., Bauer D.C., and Harris T. Measuring fitness in healthy older adults: the Health ABC Long Distance Corridor Walk. J Am Geriatr Soc 49 (2001) 1544-1548
18. Goodpaster B.H., Carlson C.L., Visser M., et al. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol 90 (2001) 2157-2165
19. Manini T.M., Visser M., Won-Park S., et al. Knee extension strength cutpoints for maintaining mobility. J Am Geriatr Soc 55 (2007) 451-457
20. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 (2003) 2317-2322
21. Lee E.T., and Wang J.W. Statistical methods for survival data analysis. 3rd ed (2003), John Wiley & Sons Inc, Hoboken (NJ)
22. Henderson A.R. The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data. Clin Chim Acta 359 (2005) 1-26
23. Altman D.G., and Royston P. What do we mean by validating a prognostic model?. Stat Med 19 (2000) 453-473
24. Pencina M.J., and D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23 (2004) 2109-2123
25. Friedman G.D., Klatsky A.L., and Siegelaub A.B. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 294 (1976) 1071-1075
26. Hole D.J., Watt G.C., Davey-Smith G., Hart C.L., Gillis C.R., and Hawthorne V.M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313 (1996) 711-715
27. Knuiman M.W., James A.L., Divitini M.L., Ryan G., Bartholomew H.C., and Musk A.W. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 9 (1999) 297-306
28. Weiss S.T., Segal M.R., Sparrow D., and Wager C. Relation of FEV1 and peripheral blood leukocyte count to total mortality. The Normative Aging Study. Am J Epidemiol 142 (1995) 493-498
29. Mahler D.A., Weinberg D.H., Wells C.K., and Feinstein A.R. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 85 (1984) 751-758
30. Nishimura K., Izumi T., Tsukino M., and Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121 (2002) 1434-1440
31. Isoaho R., Puolijoki H., Huhti E., Kivela S.L., Laippala P., and Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med 88 (1994) 571-580
32. Littlejohns P., Ebrahim S., and Anderson R. Prevalence and diagnosis of chronic respiratory symptoms in adults. BMJ 298 (1989) 1556-1560
33. Gan W.Q., Man S.F., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 (2004) 574-580
34. Jette D.U., Manago D., Medved E., Nickerson A., Warzycha T., and Bourgeois M.C. The disablement process in patients with pulmonary disease. Phys Ther 77 (1997) 385-394
35. Wouters E.F., Creutzberg E.C., and Schols A.M. Systemic effects in COPD. Chest 121 (2002) 127S-130S
36. Gosselink R., Troosters T., and Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153 (1996) 976-980
37. Hamilton A.L., Killian K.J., Summers E., and Jones N.L. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 152 (1995) 2021-2031
38. Bernard S., LeBlanc P., Whittom F., et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 629-634
39. Heijdra Y.F., Pinto-Plata V., Frants R., Rassulo J., Kenney L., and Celli B.R. Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 124 (2003) 75-82
40. Sin D.D., and Man S.F. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?. Thorax 61 (2006) 1-3
41. de Godoy I., Donahoe M., Calhoun W.J., Mancino J., and Rogers R.M. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 153 (1996) 633-637
42. Di Francia M., Barbier D., Mege J.L., and Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150 (1994) 1453-1455
43. Eid A.A., Ionescu A.A., Nixon L.S., et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1414-1418
44. Schols A.M., Slangen J., Volovics L., and Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
45. Dahl M., Vestbo J., Lange P., Bojesen S.E., Tybjaerg-Hansen A., and Nordestgaard B.G. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 (2007) 250-255
46. Stolz D., Christ-Crain M., Morgenthaler N.G., et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 131 (2007) 1058-1067
47. Broekhuizen R., Wouters E.F., Creutzberg E.C., and Schols A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61 (2006) 17-22
48. Man S.F., Connett J.E., Anthonisen N.R., Wise R.A., Tashkin D.P., and Sin D.D. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 61 (2006) 849-853
49. Stanojevic S., Wade A., Stocks J., et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 177 (2008) 253-260
50. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106 (1999) 506-512
51. Sciurba F.C. Physiologic similarities and differences between COPD and asthma. Chest 126 (2004) 117S-124S discussion 159S-161S